The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Cytokine function in medication-naive first episode psychosis: A systematic review and meta-analysis
Abstract
This systematic review sets out to give a comprehensive overview of the cytokine profile at the onset of psychosis un-confounded by medication. We aim to provide insight into the early pathophysiological process of psychosis and areas for future research of potential biomarkers able to chart the extent of illness or effectiveness of treatment. Following PRISMA guidelines, a systematic primary search identified 4638 citations, 4651 studies were retrieved and screened, and 23 studies met the inclusion criteria (published in English before June 2013, patients with neuroleptic naive first episode psychosis, and assessed circulating cytokines). These reported 570 patients, 683 healthy control subjects, and 20 cytokine/cytokine receptors. Papers that contained sufficient stratified data were included in a random-effects pooled effect size meta-analysis. Highly significant effect sizes were found for elevated IL-1β, sIL-2r, IL-6, and TNF-α. Non-significant effect size estimates were obtained for IL-2, IL-4, and IFN-γ. Thus, we found significant elevation in pro-inflammatory cytokine levels in the serum of patients with medication-naive first episode psychosis. This adds to the evidence of a pro-inflammatory immune deregulation in schizophrenia and suggests these cytokines should be the focus for further research in biomarkers of progress and extent of illness. Future studies should focus on the medication-naive group at the early stages of illness with numbers large enough to allow for the control of other potential confounding factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In our data, the difference of IL-12 levels in CSF between SCZ and controls was not significant13,46;”
From Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses (2019) · cites this paper as [46]
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
van Os, J., & Kapur, S. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60995-8 · Cited by 1,971
Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects
Miller, B. J., Buckley, P., Seabolt, W., Mellor, A., & Kirkpatrick, B. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.04.013 · Cited by 1,742
Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review
Potvin, S., Stip, E., Sepehry, A. A., Gendron, A., Bah, R., & Kouassi, E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.024 · Cited by 858
Abnormal gray and white matter volume in delusional infestation
Wolf, R. C., Huber, M. K., Depping, M. S., Thomann, P. A., Kärner, M., Lepping, P., & Freudenmann, R. W. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.004 · Cited by 606
The genetics of schizophrenia and bipolar disorder: dissecting psychosis
Craddock, N., O’Donovan, M. C., & Owen, M. J. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030718 · Cited by 574
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529
Cytokines and schizophrenia: microglia hypothesis of schizophrenia
Monji, A., Kato, T., & Kanba, S. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01945.x · Cited by 508
Häfner, H., & der Heiden, W. A. (1997) · The Canadian Journal of Psychiatry · doi:10.1177/070674379704200204 · Cited by 437
Season of birth in schizophrenia: A review of evidence, methodology, and etiology.
Bradbury, T. N., & Miller, G. A. (1985) · Psychological Bulletin · doi:10.1037/0033-2909.98.3.569 · Cited by 344
The Role of Immune System in Schizophrenia
Müller, N., & Schwarz, M. (2010) · Current Immunology Reviews · doi:10.2174/157339510791823673 · Cited by 300
Chaudhry, I. B., Hallak, J. E. C., Husain, N., Minhas, F., Stirling, J., Richardson, P., Dursun, S. M., Dunn, G., & Deakin, J. F. W. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444941 · Cited by 284
Cytokines in schizophrenia and the effects of antipsychotic drugs
Drzyzga, Ł. R., Obuchowicz, E., Marcinowska, A., & Herman, Z. S. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.02.002 · Cited by 242
Metabolic profile of antipsychotic-naive individuals with non-affective psychosis
Fernández-Egea, E., Bernardo, M., Donner, T. W., Conget, I., Parellada, E., Justicia, A., Esmatjes, E., García‐Rizo, C., & Kirkpatrick, B. W. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.052605 · Cited by 242
One year outcome in first episode psychosis: influence of DUP and other predictors
MALLA, A. K. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00254-7 · Cited by 234
The evolution of depression and suicidality in first episode psychosis
Upthegrove, R., Birchwood, M. J., Ross, K., Brunett, K., McCollum, R., & Jones, L. A. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01506.x · Cited by 224
Self-citationThe macrophage-T-lymphocyte theory of schizophrenia: Additional evidence
Smith, R. S., & Maes, M. H. J. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90062-4 · Cited by 222
Serum interleukin-6 concentration in schizophrenia: Elevation associated with duration of illness
Ganguli, R., Yang, Z., Shurin, G. V., Chengappa, K. N. R., Brar, J. S., Gubbi, A. V., & Rabin, B. S. (1994) · Psychiatry Research · doi:10.1016/0165-1781(94)90042-6 · Cited by 222
Serum and gene expression profile of cytokines in first-episode psychosis
Di Nicola, M., Cattaneo, A., Hepgul, N., Di Forti, M., Aitchison, K. J., Janiri, L., Murray, R. M., Dazzan, P., Pariante, C. M., & Mondelli, V. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.06.010 · Cited by 217
Fineberg, A. M., & Ellman, L. M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.001 · Cited by 206
Th1, Th2 and Th3 cytokine alteration in schizophrenia
Kim, Y., Myint, A.-M., Lee, B.-H., Han, C.-S., Lee, H., Kim, D.-J., & Leonard, B. E. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.05.047 · Cited by 190
Theodoropoulou, S., Spanakos, G., Baxevanis, C. N., Economou, M., Gritzapis, A. D., Papamichail, M., & Stefanis, C. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00007-4 · Cited by 187
The Interaction of Nuclear Factor-Kappa B and Cytokines Is Associated with Schizophrenia
Song, X., Lv, L., Li, W., Hao, Y., & Zhao, J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.018 · Cited by 187
Kim, Y., Kim, L., & Lee, M. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00171-1 · Cited by 159
Bian, Q., Kato, T. A., Monji, A., Hashioka, S., Mizoguchi, Y., Horikawa, H., & Kanba, S. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.06.031 · Cited by 155
Jones, A. L., Mowry, B. J., Pender, M. P., & Greer, J. M. (2005) · Immunology and Cell Biology · doi:10.1111/j.1440-1711.2005.01305.x · Cited by 155
Borovčanin, M., Jovanović, I., Radosavljevic, G. D., Dejanovic, S. D., Banković, D., Arsenijević, N., & Lukić, M. L. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.08.016 · Cited by 150
Elevated Levels of Soluble Interleukin 2 Receptors in Schizophrenia
Rapaport, M. H. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810030097017 · Cited by 144
The American Psychiatric Publishing Textbook of Schizophrenia
(2007) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e318033a46f · Cited by 138
Season of Birth in Schizophrenia
O’Callaghan, E., Gibson, T., Colohan, H. A., Walshe, D. G., Buckley, P., Larkin, C., & Waddington, J. L. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.158.6.764 · Cited by 138
Kim, Y., Myint, A.-M., Verkerk, R. M., Scharpé, S., Steinbusch, H. W. M., & Leonard, B. E. (2009) · Neuropsychobiology · doi:10.1159/000213565 · Cited by 135
Kowalski, J., Blada, P., Kucia, K. A., Madej, A., & Herman, Z. S. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00156-0 · Cited by 128
Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls
Reale, M., Patruno, A., Lutiis, M. A. D., Pesce, M., Felaco, M., Giannantonio, M. D., Nicola, M. D., & Grilli, A. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-13 · Cited by 126
Akiyama, K. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00140-6 · Cited by 109
The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view
Müller, N., & Schwarz, M. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_33 · Cited by 107
Rapaport, M. H., & Lohr, J. B. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01599.x · Cited by 99
Cytokine profiles in schizophrenic patients treated with risperidone
Cazzullo, C. L., Sacchetti, E., Galluzzo, A., Panariello, A., Adorni, A., Pegoraro, M., Bosis, S., Colombo, F., Trabattoni, D., Zagliani, A., et al. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00221-4 · Cited by 89
García‐Rizo, C., Fernández-Egea, E., Oliveira, C., Justicia, A., Bernardo, M., & Kirkpatrick, B. W. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.08.014 · Cited by 89
Close encounters of the monoamine kind: immune cells betray their nervous disposition
Meredith, E. J., Chamba, A., Holder, M. J., Barnes, N. M., & Gordon, J. (2005) · Immunology · doi:10.1111/j.1365-2567.2005.02166.x · Cited by 83
Self-citationBorovčanin, M., Jovanović, I., Radosavljevic, G. D., Dejanovic, S. D., Stefanović, V., Arsenijević, N., & Lukić, M. L. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.03.027 · Cited by 82
Cytokine profiles in drug-naive schizophrenic patients
Cazzullo, C. L., Sacchetti, E., Galluzzo, A., Panariello, A., Colombo, F., Zagliani, A., & Clerici, M. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00046-3 · Cited by 80
Seki, Y., Kato, T. A., Monji, A., Mizoguchi, Y., Horikawa, H., Sato‐Kasai, M., Yoshiga, D., & Kanba, S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.09.011 · Cited by 72
Gattaz, W. F., Dalgalarrondo, P., & Schröder, H. C. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90006-q · Cited by 64
Kato, T. A., Monji, A., Yasukawa, K., Mizoguchi, Y., Horikawa, H., Seki, Y., Hashioka, S., Han, Y.-H., Kasai, M., Sonoda, N., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.019 · Cited by 63
Crespo‐Facorro, B., Carrasco-Marı́n, E., Pérez‐Iglesias, R., Pelayo‐Terán, J. M., Fernández-Prieto, L., Leyva‐Cobián, F., & Vázquez‐Barquero, J. L. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2006.08.005 · Cited by 55
Elevated interleukin-18 serum levels in chronic schizophrenia: Association with psychopathology
Xiu, M. H., Chen, D. C., Wang, D., Zhang, K., Dong, A., Tang, W., Zhang, F., Liu, L. J., Liu, J. H., Liu, H. B., et al. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.04.026 · Cited by 53
The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia
Xiong, P., Zeng, Y., Wan, J., XiaoHan, D. H., Tan, D., Lü, J., Xu, F., Li, H. Y., Zhu, Z., & Ma, M. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.12.017 · Cited by 52
Sirota, P., Meiman, M. E., Hershko, R., & Bessler, H. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.012 · Cited by 51
Serum Interferon in First Psychotic Attack
Becker, D., Kritschmann, E., Floru, S., Shlomo-David, Y., & Gotlieb‐Stematsky, T. (1990) · The British Journal of Psychiatry · doi:10.1192/bjp.157.1.136 · Cited by 31
The immune system and schizophrenia: an update for clinicians
Upthegrove, R., & Barnes, N. M. (2014) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.113.011452 · Cited by 27
Self-citationNeuropsychiatric Disorders: An Integrative Approach
(2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1048 · Cited by 25
Neuropsychiatric Disorders An Integrative Approach
Gerlach, M., Koutsilieri, E., Double, K. L., & Deckert, J. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9 · Cited by 19
Altered interleukin-3 serum levels in drug-naïve and neuroleptic-treated schizophrenic patients
Xiu, M., CHEN, S., WANG, F., Cao, L., Qi, L. Y., CHEN, D., Wu, G. Y., Lü, L., Kosten, T. A., & KOSTEN, T. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.001 · Cited by 11
Flagged first, then by citations
Research works printed but not linked: 2
- Dameshek, 1930, White blood cells in dementia praecox and dementia paralytica, Arch. Neurol. Psychiatry, 24, 855
- Müller, 2011, Inflammation and schizophrenia: pathophysiological and therapeutic aspects, Minerva Psichiatr., 52, 205
Cited by
Sorted by citations
Goldsmith, D. R., Rapaport, M. H., & Miller, B. J. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.3 · Cited by 1,683
Maternal immune activation and abnormal brain development across CNS disorders
Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., Toovey, S., & Prinssen, E. P. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.187 · Cited by 880
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
Khandaker, G. M., Cousins, L., Deakin, J., Lennox, B. R., Yolken, R., & Jones, P. B. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00122-9 · Cited by 926
The intriguing relationship between coronary heart disease and mental disorders
Binder, M. D., Detraux, J., & Vancampfort, D. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.1/mdehert · Cited by 506
Yuan, N., Chen, Y., Xia, Y., Dai, J., & Liu, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0570-y · Cited by 428
Metadata
- Authors
- Upthegrove, R., Manzanares-Teson, N., & Barnes, N. M.
- Affiliations
- Birmingham and Solihull Mental Health NHS Foundation Trust (GB)
- University of Birmingham (GB)
- Corresponding author
- Upthegrove, Rachel
- Venue
- Schizophrenia Research
- Publisher
- Elsevier BV
- Published
- 2014-05
- Volume
- 155
- Issue
- 1-3
- Pages
- 101-108
- ISSN
- 0920-9964 (ISSN-L)
- OpenAlex
- W1969833165
- Cited by
- 501
- References
- 57
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 34 · 2023: 46 · 2022: 41 · 2021: 51 · 2020: 42 · 2019: 48 · 2018: 52 · 2017: 47 · 2016: 37 · 2015: 28 · 2014: 7
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Schizophrenia Research (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- first-episode psychosis, cytokines
- MeSH terms
- Humans, Psychotic Disorders, Antipsychotic Agents, Cytokines, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
